NATIONAL CANCER CENTER OF CHINA · SUPREME ONCOLOGY CLINICAL & RESEARCH INSTITUTION

Cancer Hospital, Chinese Academy of Medical Sciences (CICAMS)

Founded in 1958, the Cancer Hospital of the Chinese Academy of Medical Sciences (CICAMS) is the flagship national institution for cancer prevention and treatment in China. Anchored as the National Cancer Center of China (NCCC), CICAMS serves as the nation’s supreme clinical and scientific authority, responsible for drafting China’s National Cancer Clinical Practice Guidelines.

With over 2,300 specialized beds and conducting more than 600 active international and domestic clinical trials, CICAMS leads Asia in complex thoracic surgical oncology (lung and esophageal cancer), head and neck reconstructive surgery, and groundbreaking novel immuno-oncology trials.

National Cancer Center of China Panjiayuan Beijing
Beijing Panjiayuan Headquarters Located at 17 Panjiayuan Nanli, Chaoyang District, Beijing, adjacent to the Central Business District with direct transit links.
Est. 1958
National Cancer Center
Supreme national oncology authority
2,300+
Cancer Beds
Dedicated oncology inpatient capacity
600+
Active Trials
Leader in global oncology research
#1 Nationally
Thoracic Surgery
National guideline formulating hospital

FOUR CLINICAL EXCELLENCE PILLARS

Core Thoracic & Medical Oncology Capabilities

CICAMS sets national standards in complex surgical resections, image-guided radiotherapy, and early-phase novel drug development.

Thoracic Surgical Oncology

World leader in complex pulmonary resections, sleeve lobectomies, and minimally invasive esophageal carcinoma surgery.

✓ Accredited Clinical Excellence Pillar

Medical Oncology & Novel Trials

National coordinating center for first-in-human clinical trials of novel bispecific antibodies, ADCs, and cell therapies.

✓ Accredited Clinical Excellence Pillar

Precision Radiotherapy

Advanced helical TomoTherapy, CyberKnife, and TrueBeam fleets delivering sub-millimeter stereotactic body radiotherapy.

✓ Accredited Clinical Excellence Pillar

Head & Neck Surgery

Organ-preserving microvascular free-flap reconstruction for advanced oral, laryngeal, and hypopharyngeal malignancies.

✓ Accredited Clinical Excellence Pillar

MEMBERS OF THE CHINESE ACADEMY OF SCIENCES & ENGINEERING

Academic Faculty & Department Leadership

Led by national oncology directors who formulate China’s national treatment standards.

Academician He Jie, MD, PhD

Academician He Jie, MD, PhD

Director of National Cancer Center · Member, Chinese Academy of Sciences

Internationally celebrated thoracic surgical oncologist who established national standards for esophageal and lung cancer surgery. Academician He leads China’s highest-volume complex thoracic resection programs.

Focus: Complex sleeve lobectomies, minimally invasive McKeown esophagectomy, early lung cancer screening guidelines.
View Full Academician / Specialist Profile →
Academician Xu Binghe, MD, PhD

Academician Xu Binghe, MD, PhD

Director of Medical Oncology · Member, Chinese Academy of Engineering

National leader in medical oncology and molecular targeted therapeutics. Academician Xu has led hundreds of registrational clinical trials that brought breakthrough targeted therapies to international practice.

Focus: Advanced breast cancer, novel ADCs and bispecific antibodies, clinical trial governance, molecular targeted therapy.
Request Case Review with This Specialist →

CASE INTAKE & SPECIALIST TRIAGE

Initiate Your Case Review with CICAMS / National Cancer Center

Submit your contact details, confirmed diagnosis, and main question below. You do not need to upload any medical files at this stage. Our clinical coordinator will contact you directly within 24–48 hours to discuss potential CICAMS Cancer Hospital pathways in China and assist you in gathering the specific medical records needed for expert hospital review.

    PATIENT INQUIRIES

    Frequently Asked Questions About CICAMS / National Cancer Center

    Key clinical, logistical, and technical facts regarding international admissions, surgical evaluations, advanced technology access, and personalized care coordination at CICAMS / National Cancer Center.

    CICAMS conducts over 600 active clinical trials. Following initial molecular and pathology review, our team evaluates patients against specific genomic and clinical eligibility criteria for innovative trial entry.

    Yes. CICAMS thoracic and abdominal surgical chiefs specialize in complex salvage resections, including sleeve lobectomies, carinal resections, and vascular reconstructions for locally advanced tumors.

    CICAMS is the National Cancer Center of China (NCCC), responsible for formulating national cancer screening guidelines, standardizing treatment pathways, and leading multi-center clinical trials nationwide.

    High-resolution DICOM CT/MRI/PET scans performed within the past 4 weeks, original biopsy pathology reports, surgical operative notes, and molecular biomarker testing records.

    MODERN CLINICAL INFRASTRUCTURE

    Strategic Multi-Campus Setup & International Transit

    Modern clinical hubs designed for seamless aeromedical transport, multidisciplinary conferences, and dedicated international inpatient care.

    National Headquarters

    Panjiayuan Main Campus

    17 Panjiayuan Nanli, Chaoyang District, Beijing

    Primary clinical headquarters housing the National Cancer Center administration, inpatient surgical wards, and research labs.

    Langfang Regional Hub

    CICAMS Langfang Campus

    Langfang High-Tech Medical Zone, Hebei / Beijing South

    Modern expanded clinical facility featuring specialized advanced radiation oncology suites and regional inpatient wings.

    Cancer Hospital, Chinese Academy of Medical Sciences (CICAMS)